Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cytotoxic Effects of Environmental Toxins on Human Glial Cells.

Identifieur interne : 003D89 ( Ncbi/Merge ); précédent : 003D88; suivant : 003D90

Cytotoxic Effects of Environmental Toxins on Human Glial Cells.

Auteurs : Fiona D'Mello [Australie] ; Nady Braidy [Australie] ; Helder Marçal [Australie] ; Gilles Guillemin [Australie] ; Fanny Rossi [France] ; Mirielle Chinian [Polynésie française] ; Dominique Laurent [France] ; Charles Teo [Australie] ; Brett A. Neilan [Australie]

Source :

RBID : pubmed:27796937

Descripteurs français

English descriptors

Abstract

Toxins produced by cyanobacteria and dinoflagellates have increasingly become a public health concern due to their degenerative effects on mammalian tissue and cells. In particular, emerging evidence has called attention to the neurodegenerative effects of the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA). Other toxins such as the neurotoxins saxitoxin and ciguatoxin, as well as the hepatotoxic microcystin, have been previously shown to have a range of effects upon the nervous system. However, the capacity of these toxins to cause neurodegeneration in human cells has not, to our knowledge, been previously investigated. This study aimed to examine the cytotoxic effects of BMAA, microcystin-LR (MC-LR), saxitoxin (STX) and ciguatoxin (CTX-1B) on primary adult human astrocytes. We also demonstrated that α-lipoate attenuated MC-LR toxicity in primary astrocytes and characterised changes in gene expression which could potentially be caused by these toxins in primary astrocytes. Herein, we are the first to show that all of these toxins are capable of causing physiological changes consistent with neurodegeneration in glial cells, via oxidative stress and excitotoxicity, leading to a reduction in cell proliferation culminating in cell death. In addition, MC-LR toxicity was reduced significantly in astrocytes-treated α-lipoic acid. While there were no significant changes in gene expression, many of the probes that were altered were associated with neurodegenerative disease pathogenesis. Overall, this is important in advancing our current understanding of the mechanism of toxicity of MC-LR on human brain function in vitro, particularly in the context of neurodegeneration.

DOI: 10.1007/s12640-016-9678-5
PubMed: 27796937

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27796937

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cytotoxic Effects of Environmental Toxins on Human Glial Cells.</title>
<author>
<name sortKey="D Mello, Fiona" sort="D Mello, Fiona" uniqKey="D Mello F" first="Fiona" last="D'Mello">Fiona D'Mello</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Braidy, Nady" sort="Braidy, Nady" uniqKey="Braidy N" first="Nady" last="Braidy">Nady Braidy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, The University of New South Wales, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, The University of New South Wales, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Marcal, Helder" sort="Marcal, Helder" uniqKey="Marcal H" first="Helder" last="Marçal">Helder Marçal</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Guillemin, Gilles" sort="Guillemin, Gilles" uniqKey="Guillemin G" first="Gilles" last="Guillemin">Gilles Guillemin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Faculty of Medicine and Health Science, Neuroinflammation group, Macquarie University, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Faculty of Medicine and Health Science, Neuroinflammation group, Macquarie University, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rossi, Fanny" sort="Rossi, Fanny" uniqKey="Rossi F" first="Fanny" last="Rossi">Fanny Rossi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chinian, Mirielle" sort="Chinian, Mirielle" uniqKey="Chinian M" first="Mirielle" last="Chinian">Mirielle Chinian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ecosystèmes Insulaires Océaniens UMR-241, Institut Louis Malardé, Laboratoire de recherche sur les Microalgues Toxiques, BP 30, 98713, Tahiti, Papeete, French Polynesia.</nlm:affiliation>
<country xml:lang="fr">Polynésie française</country>
<wicri:regionArea>Ecosystèmes Insulaires Océaniens UMR-241, Institut Louis Malardé, Laboratoire de recherche sur les Microalgues Toxiques, BP 30, 98713, Tahiti, Papeete</wicri:regionArea>
<wicri:noRegion>Papeete</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Laurent, Dominique" sort="Laurent, Dominique" uniqKey="Laurent D" first="Dominique" last="Laurent">Dominique Laurent</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse</wicri:regionArea>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Teo, Charles" sort="Teo, Charles" uniqKey="Teo C" first="Charles" last="Teo">Charles Teo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Neilan, Brett A" sort="Neilan, Brett A" uniqKey="Neilan B" first="Brett A" last="Neilan">Brett A. Neilan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia. b.neilan@unsw.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27796937</idno>
<idno type="pmid">27796937</idno>
<idno type="doi">10.1007/s12640-016-9678-5</idno>
<idno type="wicri:Area/PubMed/Corpus">001172</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001172</idno>
<idno type="wicri:Area/PubMed/Curation">001169</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001169</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001169</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001169</idno>
<idno type="wicri:Area/Ncbi/Merge">003D89</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Cytotoxic Effects of Environmental Toxins on Human Glial Cells.</title>
<author>
<name sortKey="D Mello, Fiona" sort="D Mello, Fiona" uniqKey="D Mello F" first="Fiona" last="D'Mello">Fiona D'Mello</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Braidy, Nady" sort="Braidy, Nady" uniqKey="Braidy N" first="Nady" last="Braidy">Nady Braidy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, The University of New South Wales, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, The University of New South Wales, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Marcal, Helder" sort="Marcal, Helder" uniqKey="Marcal H" first="Helder" last="Marçal">Helder Marçal</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Guillemin, Gilles" sort="Guillemin, Gilles" uniqKey="Guillemin G" first="Gilles" last="Guillemin">Gilles Guillemin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Faculty of Medicine and Health Science, Neuroinflammation group, Macquarie University, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Faculty of Medicine and Health Science, Neuroinflammation group, Macquarie University, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rossi, Fanny" sort="Rossi, Fanny" uniqKey="Rossi F" first="Fanny" last="Rossi">Fanny Rossi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chinian, Mirielle" sort="Chinian, Mirielle" uniqKey="Chinian M" first="Mirielle" last="Chinian">Mirielle Chinian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ecosystèmes Insulaires Océaniens UMR-241, Institut Louis Malardé, Laboratoire de recherche sur les Microalgues Toxiques, BP 30, 98713, Tahiti, Papeete, French Polynesia.</nlm:affiliation>
<country xml:lang="fr">Polynésie française</country>
<wicri:regionArea>Ecosystèmes Insulaires Océaniens UMR-241, Institut Louis Malardé, Laboratoire de recherche sur les Microalgues Toxiques, BP 30, 98713, Tahiti, Papeete</wicri:regionArea>
<wicri:noRegion>Papeete</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Laurent, Dominique" sort="Laurent, Dominique" uniqKey="Laurent D" first="Dominique" last="Laurent">Dominique Laurent</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse</wicri:regionArea>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Teo, Charles" sort="Teo, Charles" uniqKey="Teo C" first="Charles" last="Teo">Charles Teo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Neilan, Brett A" sort="Neilan, Brett A" uniqKey="Neilan B" first="Brett A" last="Neilan">Brett A. Neilan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia. b.neilan@unsw.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052</wicri:regionArea>
<wicri:noRegion>2052</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Neurotoxicity research</title>
<idno type="eISSN">1476-3524</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acids, Diamino (toxicity)</term>
<term>Astrocytes (drug effects)</term>
<term>Astrocytes (metabolism)</term>
<term>Calcium (metabolism)</term>
<term>Cell Proliferation (drug effects)</term>
<term>Ciguatoxins (toxicity)</term>
<term>Gene Expression (drug effects)</term>
<term>Humans</term>
<term>L-Lactate Dehydrogenase (metabolism)</term>
<term>Microcystins (antagonists & inhibitors)</term>
<term>Microcystins (toxicity)</term>
<term>Nerve Degeneration (chemically induced)</term>
<term>Primary Cell Culture</term>
<term>Reactive Oxygen Species (metabolism)</term>
<term>Saxitoxin (toxicity)</term>
<term>Thioctic Acid (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide lipoïque (pharmacologie)</term>
<term>Acides aminés diaminés (toxicité)</term>
<term>Astrocytes ()</term>
<term>Astrocytes (métabolisme)</term>
<term>Calcium (métabolisme)</term>
<term>Ciguatoxines (toxicité)</term>
<term>Culture primaire de cellules</term>
<term>Dégénérescence nerveuse ()</term>
<term>Espèces réactives de l'oxygène (métabolisme)</term>
<term>Expression des gènes ()</term>
<term>Humains</term>
<term>L-Lactate dehydrogenase (métabolisme)</term>
<term>Microcystines (antagonistes et inhibiteurs)</term>
<term>Microcystines (toxicité)</term>
<term>Prolifération cellulaire ()</term>
<term>Saxitoxine (toxicité)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Microcystins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Calcium</term>
<term>L-Lactate Dehydrogenase</term>
<term>Reactive Oxygen Species</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Thioctic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en">
<term>Amino Acids, Diamino</term>
<term>Ciguatoxins</term>
<term>Microcystins</term>
<term>Saxitoxin</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Microcystines</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Astrocytes</term>
<term>Cell Proliferation</term>
<term>Gene Expression</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Astrocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Astrocytes</term>
<term>Calcium</term>
<term>Espèces réactives de l'oxygène</term>
<term>L-Lactate dehydrogenase</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acide lipoïque</term>
</keywords>
<keywords scheme="MESH" qualifier="toxicité" xml:lang="fr">
<term>Acides aminés diaminés</term>
<term>Ciguatoxines</term>
<term>Microcystines</term>
<term>Saxitoxine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Primary Cell Culture</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Astrocytes</term>
<term>Culture primaire de cellules</term>
<term>Dégénérescence nerveuse</term>
<term>Expression des gènes</term>
<term>Humains</term>
<term>Prolifération cellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Toxins produced by cyanobacteria and dinoflagellates have increasingly become a public health concern due to their degenerative effects on mammalian tissue and cells. In particular, emerging evidence has called attention to the neurodegenerative effects of the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA). Other toxins such as the neurotoxins saxitoxin and ciguatoxin, as well as the hepatotoxic microcystin, have been previously shown to have a range of effects upon the nervous system. However, the capacity of these toxins to cause neurodegeneration in human cells has not, to our knowledge, been previously investigated. This study aimed to examine the cytotoxic effects of BMAA, microcystin-LR (MC-LR), saxitoxin (STX) and ciguatoxin (CTX-1B) on primary adult human astrocytes. We also demonstrated that α-lipoate attenuated MC-LR toxicity in primary astrocytes and characterised changes in gene expression which could potentially be caused by these toxins in primary astrocytes. Herein, we are the first to show that all of these toxins are capable of causing physiological changes consistent with neurodegeneration in glial cells, via oxidative stress and excitotoxicity, leading to a reduction in cell proliferation culminating in cell death. In addition, MC-LR toxicity was reduced significantly in astrocytes-treated α-lipoic acid. While there were no significant changes in gene expression, many of the probes that were altered were associated with neurodegenerative disease pathogenesis. Overall, this is important in advancing our current understanding of the mechanism of toxicity of MC-LR on human brain function in vitro, particularly in the context of neurodegeneration.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27796937</PMID>
<DateCreated>
<Year>2016</Year>
<Month>10</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>10</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>11</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-3524</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>31</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Neurotoxicity research</Title>
<ISOAbbreviation>Neurotox Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Cytotoxic Effects of Environmental Toxins on Human Glial Cells.</ArticleTitle>
<Pagination>
<MedlinePgn>245-258</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-016-9678-5</ELocationID>
<Abstract>
<AbstractText>Toxins produced by cyanobacteria and dinoflagellates have increasingly become a public health concern due to their degenerative effects on mammalian tissue and cells. In particular, emerging evidence has called attention to the neurodegenerative effects of the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA). Other toxins such as the neurotoxins saxitoxin and ciguatoxin, as well as the hepatotoxic microcystin, have been previously shown to have a range of effects upon the nervous system. However, the capacity of these toxins to cause neurodegeneration in human cells has not, to our knowledge, been previously investigated. This study aimed to examine the cytotoxic effects of BMAA, microcystin-LR (MC-LR), saxitoxin (STX) and ciguatoxin (CTX-1B) on primary adult human astrocytes. We also demonstrated that α-lipoate attenuated MC-LR toxicity in primary astrocytes and characterised changes in gene expression which could potentially be caused by these toxins in primary astrocytes. Herein, we are the first to show that all of these toxins are capable of causing physiological changes consistent with neurodegeneration in glial cells, via oxidative stress and excitotoxicity, leading to a reduction in cell proliferation culminating in cell death. In addition, MC-LR toxicity was reduced significantly in astrocytes-treated α-lipoic acid. While there were no significant changes in gene expression, many of the probes that were altered were associated with neurodegenerative disease pathogenesis. Overall, this is important in advancing our current understanding of the mechanism of toxicity of MC-LR on human brain function in vitro, particularly in the context of neurodegeneration.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>D'Mello</LastName>
<ForeName>Fiona</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Braidy</LastName>
<ForeName>Nady</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, The University of New South Wales, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marçal</LastName>
<ForeName>Helder</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guillemin</LastName>
<ForeName>Gilles</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Medicine and Health Science, Neuroinflammation group, Macquarie University, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rossi</LastName>
<ForeName>Fanny</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Institut de Recherche pour le Développement (IRD), UMR-152, BP 529, 98713, Tahiti, Papeete, French Polynesia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Pacific Biotech SAS, BP 140 289, 98701, Tahiti, Arue, French Polynesia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Ecosystèmes Insulaires Océaniens, UMR-241, Université de la Polynésie française, BP 6570, 98702, Tahiti, Faa'a, French Polynesia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chinian</LastName>
<ForeName>Mirielle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Ecosystèmes Insulaires Océaniens UMR-241, Institut Louis Malardé, Laboratoire de recherche sur les Microalgues Toxiques, BP 30, 98713, Tahiti, Papeete, French Polynesia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laurent</LastName>
<ForeName>Dominique</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Université de Toulouse, UPS, UMR-152 (Pharma-Dev), rte de Narbonne, cedex 9, F-31062, Toulouse, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Institut de Recherche pour le Développement (IRD), UMR-152, BP 529, 98713, Tahiti, Papeete, French Polynesia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Teo</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neilan</LastName>
<ForeName>Brett A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, 2052, Australia. b.neilan@unsw.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>10</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurotox Res</MedlineTA>
<NlmUniqueID>100929017</NlmUniqueID>
<ISSNLinking>1029-8428</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000599">Amino Acids, Diamino</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052998">Microcystins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>108SA6URTV</RegistryNumber>
<NameOfSubstance UI="C001824">beta-N-methylamino-L-alanine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>11050-21-8</RegistryNumber>
<NameOfSubstance UI="D002922">Ciguatoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>35523-89-8</RegistryNumber>
<NameOfSubstance UI="D012530">Saxitoxin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73Y7P0K73Y</RegistryNumber>
<NameOfSubstance UI="D008063">Thioctic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.27</RegistryNumber>
<NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EQ8332842Y</RegistryNumber>
<NameOfSubstance UI="C057862">cyanoginosin LR</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>SY7Q814VUP</RegistryNumber>
<NameOfSubstance UI="D002118">Calcium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 1989;568:234-51</RefSource>
<PMID Version="1">2576507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Toxicol. 2014 Mar;29(3):261-8</RefSource>
<PMID Version="1">22223477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Scand. 2004 Oct;110(4):267-9</RefSource>
<PMID Version="1">15355492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2007 Jun;114(3):261-77</RefSource>
<PMID Version="1">17399794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2004 Oct 25;167(2):209-13</RefSource>
<PMID Version="1">15504908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2009 Aug;5(8):e1000604</RefSource>
<PMID Version="1">19680447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Gerontol. 2004 Feb;39(2):263-8</RefSource>
<PMID Version="1">15036421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Rep. 2013;3:1482</RefSource>
<PMID Version="1">23508043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Lett. 2004 Mar 14;148(1-2):53-63</RefSource>
<PMID Version="1">15019088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Amyotroph Lateral Scler. 2009;10 Suppl 2:34-40</RefSource>
<PMID Version="1">19929729</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009 Oct 01;4(10):e7280</RefSource>
<PMID Version="1">19794916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2006 Apr;253(4):483-7</RefSource>
<PMID Version="1">16283096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Rev. 2010 May;63(1-2):189-211</RefSource>
<PMID Version="1">19944719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Amyotroph Lateral Scler. 2009;10 Suppl 2:118-23</RefSource>
<PMID Version="1">19929743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2002 Aug 23;296(3):677-84</RefSource>
<PMID Version="1">12176035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Oct 19;443(7113):787-95</RefSource>
<PMID Version="1">17051205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Amyotroph Lateral Scler. 2009;10 Suppl 2:7-20</RefSource>
<PMID Version="1">19929726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>F1000Res. 2012 Nov 09;1:47</RefSource>
<PMID Version="1">24627764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 2010 Jan 14;468(3):225-8</RefSource>
<PMID Version="1">19922771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 1963 Nov 8;77:383-93</RefSource>
<PMID Version="1">14089413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Jun 4;285(23):17673-80</RefSource>
<PMID Version="1">20356836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Aging Neurosci. 2010 Mar 30;2:12</RefSource>
<PMID Version="1">20552050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroinflammation. 2012 Aug 11;9:195</RefSource>
<PMID Version="1">22884085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2007 Mar 1;16(5):555-66</RefSource>
<PMID Version="1">17309878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Appl Bacteriol. 1992 Jun;72 (6):445-59</RefSource>
<PMID Version="1">1644701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Bull. 2009 Oct 28;80(4-5):224-32</RefSource>
<PMID Version="1">19631259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Cell Immunol. 2014 Feb;5(1):null</RefSource>
<PMID Version="1">25133067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chemosphere. 2010 Oct;81(6):716-24</RefSource>
<PMID Version="1">20800265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2009 Oct;41(10):1088-93</RefSource>
<PMID Version="1">19734902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2000 Feb;15(2):141-55</RefSource>
<PMID Version="1">10673323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2012 Jun 15;11(12):2225-6</RefSource>
<PMID Version="1">22659797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2010 Jan;277(2):368-82</RefSource>
<PMID Version="1">20015232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2010 Apr 15;19(R1):R12-20</RefSource>
<PMID Version="1">20413653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2016 Sep 1;23 (9):1515-28</RefSource>
<PMID Version="1">27104929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytogenet Cell Genet. 2000;90(3-4):291-7</RefSource>
<PMID Version="1">11124536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genomics. 2001 May 15;74(1):12-20</RefSource>
<PMID Version="1">11374898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurochem Int. 2012 Dec;61(7):1231-41</RefSource>
<PMID Version="1">22995786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Comp Biochem Physiol C Toxicol Pharmacol. 2011 Sep;154(3):146-53</RefSource>
<PMID Version="1">21586338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2001 Oct 1;20(44):6459-72</RefSource>
<PMID Version="1">11607845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicon. 2012 Nov;60(6):1159-65</RefSource>
<PMID Version="1">22885173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Med Chem. 2004 May;11(9):1135-46</RefSource>
<PMID Version="1">15134511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Neurobiol. 2014 Feb;49(1):136-48</RefSource>
<PMID Version="1">23873136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol Methods. 1983 Dec 16;65(1-2):55-63</RefSource>
<PMID Version="1">6606682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Amyotroph Lateral Scler. 2009;10 Suppl 2:109-17</RefSource>
<PMID Version="1">19929742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Pharmacol. 1999 Aug 1;58(3):389-95</RefSource>
<PMID Version="1">10424757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pflugers Arch. 2010 Jul;460(2):525-42</RefSource>
<PMID Version="1">20229265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prion. 2013 Jan-Feb;7(1):28-36</RefSource>
<PMID Version="1">23093800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2013 Mar;51:13-26</RefSource>
<PMID Version="1">22297163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chemosphere. 2012 Sep;89(1):38-43</RefSource>
<PMID Version="1">22546629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1999 Oct 1;18(19):5321-33</RefSource>
<PMID Version="1">10508165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Methods. 1987 May;20(1):83-90</RefSource>
<PMID Version="1">2884353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurotox Res. 2014 Feb;25(2):226-34</RefSource>
<PMID Version="1">24097334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2007 Jan;113(1):154-64</RefSource>
<PMID Version="1">16989905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol Interact. 2006 Feb 25;159(3):223-34</RefSource>
<PMID Version="1">16413006</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2008 May 1;121(Pt 9):1345-7</RefSource>
<PMID Version="1">18434644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurochem. 2001 Aug;78(4):842-53</RefSource>
<PMID Version="1">11520905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2010 Apr;88(5):971-80</RefSource>
<PMID Version="1">19859963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2007 May;114(2):155-70</RefSource>
<PMID Version="1">17397930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2007 May 15;120(Pt 10):1707-16</RefSource>
<PMID Version="1">17502481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuro Oncol. 2010 Mar;12 (3):221-32</RefSource>
<PMID Version="1">20167810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2015 Mar;144(1):7-16</RefSource>
<PMID Version="1">25740792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Aging Cell. 2003 Feb;2(1):47-57</RefSource>
<PMID Version="1">12882334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2013 Feb 15;190(4):1528-39</RefSource>
<PMID Version="1">23335751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2012 Mar;33(3):518-21</RefSource>
<PMID Version="1">20570404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glia. 2011 Aug;59(8):1169-80</RefSource>
<PMID Version="1">21446047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2334-42</RefSource>
<PMID Version="1">22826245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Scand. 2009 Oct;120(4):216-25</RefSource>
<PMID Version="1">19254284</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000599" MajorTopicYN="N">Amino Acids, Diamino</DescriptorName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002922" MajorTopicYN="N">Ciguatoxins</DescriptorName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052998" MajorTopicYN="N">Microcystins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012530" MajorTopicYN="N">Saxitoxin</DescriptorName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008063" MajorTopicYN="N">Thioctic Acid</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cyanobacteria</Keyword>
<Keyword MajorTopicYN="N">Glial cells</Keyword>
<Keyword MajorTopicYN="N">Microcystin</Keyword>
<Keyword MajorTopicYN="N">Neurodegeneration</Keyword>
<Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
<Keyword MajorTopicYN="N">Oxidative stress</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>01</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>10</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>09</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>10</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27796937</ArticleId>
<ArticleId IdType="doi">10.1007/s12640-016-9678-5</ArticleId>
<ArticleId IdType="pii">10.1007/s12640-016-9678-5</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
<li>Polynésie française</li>
</country>
<region>
<li>Midi-Pyrénées</li>
<li>Nouvelle-Galles du Sud</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement>
<li>Sydney</li>
<li>Toulouse</li>
</settlement>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="D Mello, Fiona" sort="D Mello, Fiona" uniqKey="D Mello F" first="Fiona" last="D'Mello">Fiona D'Mello</name>
</noRegion>
<name sortKey="Braidy, Nady" sort="Braidy, Nady" uniqKey="Braidy N" first="Nady" last="Braidy">Nady Braidy</name>
<name sortKey="Guillemin, Gilles" sort="Guillemin, Gilles" uniqKey="Guillemin G" first="Gilles" last="Guillemin">Gilles Guillemin</name>
<name sortKey="Marcal, Helder" sort="Marcal, Helder" uniqKey="Marcal H" first="Helder" last="Marçal">Helder Marçal</name>
<name sortKey="Neilan, Brett A" sort="Neilan, Brett A" uniqKey="Neilan B" first="Brett A" last="Neilan">Brett A. Neilan</name>
<name sortKey="Teo, Charles" sort="Teo, Charles" uniqKey="Teo C" first="Charles" last="Teo">Charles Teo</name>
</country>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Rossi, Fanny" sort="Rossi, Fanny" uniqKey="Rossi F" first="Fanny" last="Rossi">Fanny Rossi</name>
</region>
<name sortKey="Laurent, Dominique" sort="Laurent, Dominique" uniqKey="Laurent D" first="Dominique" last="Laurent">Dominique Laurent</name>
</country>
<country name="Polynésie française">
<noRegion>
<name sortKey="Chinian, Mirielle" sort="Chinian, Mirielle" uniqKey="Chinian M" first="Mirielle" last="Chinian">Mirielle Chinian</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D89 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003D89 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:27796937
   |texte=   Cytotoxic Effects of Environmental Toxins on Human Glial Cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:27796937" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024